New Information

  • Home
  • >
  • New Information
  • >
  • The Regenerative Medicine Center was established in Sapporo in March 2009

The Regenerative Medicine Center will be established in Sapporo in March 2009.

Following the Tokyo, Osaka, and Fukuoka Clinics of Cosmetic Surgery Seishin, the Seishin Regenerative Medicine will be established in Sapporo in mid-March 2009. The new center provides Celution breast augmentation, or transplantation of adipose stem cells with the Celution System.

Preoperative counseling is available—application for a monitor is also accepted



Toll-free 0120-911-935 (9:30 to 20:00)
*Mobile phone and PHS are also available.

Address:
Cosmetic Surgery Seishin, Sapporo Clinic
2-5, Kita 5-jo Nishi, Chuo-ku, Sapporo-shi
JR Tower Office Plaza Sapporo 9F

Celution Following the Seishin Regenerative Medicines in Tokyo (November 2007), Osaka (May 2008), and Fukuoka (October 2008), the Seishin Regenerative Medicine opened in Sapporo in March 2009. The center offers Celution breast augmentation, or transplantation of adipose stem cells, with the Celution System, the same as in the Tokyo, Osaka, and Fukuoka Clinics.

Breast augmentation by transplantation of adipose tissue-derived stem cells is a technology that solves all the problems associated with conventional breast augmentation. In particular, the common procedures for fat injection have a low fat graft survival of about 30% to 50% due to absorption of most of the injected fat and may be associated with calcification, lump formation, and fat necrosis. In contrast, transplantation of adipose tissue-derived stem cells is expected to allow prolonged sustainment of fat with a fat graft survival of about 70% to 80%. In addition, the use of the Celution System allows extraction of stem cells at a more consistent purity and preparation of the stem cell concentrate at higher quality in a shorter period of time than manual extraction of stem cells.

In this center, with the introduction of the technology, we will expand the provision and propagation of this technology through application in the fields of breast reconstruction and cosmetic medicine (breast augmentation) in cooperation with the team of Dr. SUGIMACHI Keizo, who is professor emeritus at Kyushu University and a pioneer in the transplantation of adipose tissue-derived stem cells with the Celution System for the purpose of breast reconstruction in patients with breast cancer.

Behind this is the increase in the incidence of breast cancer and consequent breast-conserving surgery in Japan. Loss of a breast is a source of tremendous stress and mental distress for women. To provide “the joy of living” for patients through the reduction of mental distress related to the loss of a breast after cancer resection has the same meaning with Cosmetic Surgery Seishin’s therapeutic policy of “improvement in QOL with cosmetic medicine.” With this transplantation technique of adipose tissue-derived stem cells as the core, we will try to establish anti-aging medicine with self-tissue and self-ability through clinical application of the technology of regenerative medicine.

page top